| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| apixaban in cancer patients | 1.38 | 0.4 | 7407 | 93 | 27 |
| apixaban | 0.83 | 0.3 | 2377 | 50 | 8 |
| in | 1.73 | 0.6 | 7073 | 81 | 2 |
| cancer | 0.05 | 0.2 | 6824 | 94 | 6 |
| patients | 1.24 | 0.4 | 6799 | 73 | 8 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| apixaban in cancer patients | 1.61 | 0.1 | 2465 | 57 |
| apixaban information for patients | 0.46 | 0.1 | 5056 | 52 |
| why would a patient be on apixaban | 1.95 | 0.2 | 5931 | 80 |
| apixaban in patients over 120kg | 1.71 | 0.4 | 6354 | 25 |
| apixaban in obese patients | 0.36 | 0.1 | 9835 | 70 |
| apixaban in overweight patients | 0.4 | 0.5 | 2242 | 63 |
| apixaban in hd patients | 1.23 | 0.7 | 1213 | 64 |
| apixaban information leaflet for patients | 0.2 | 0.3 | 9233 | 81 |
| therapeutic effect of apixaban | 1.23 | 0.6 | 7621 | 83 |
| long term use of apixaban | 0.28 | 0.5 | 3070 | 89 |
| expected pharmacological action of apixaban | 0.03 | 0.3 | 290 | 40 |
| apixaban in renal impairment | 0.19 | 0.7 | 3344 | 7 |
| apixaban indications for use | 0.01 | 0.8 | 524 | 52 |
| apixaban in severe renal impairment | 0.71 | 0.5 | 9207 | 10 |
| reason for taking apixaban | 0.88 | 1 | 1456 | 95 |
| risk assessment for apixaban | 0.07 | 0.8 | 6132 | 50 |
| apixaban used to treat | 0.71 | 0.4 | 3677 | 17 |
| tell me about apixaban | 1.66 | 0.7 | 5830 | 42 |
| apixaban life threatening considerations | 1.07 | 0.4 | 4002 | 1 |
| apixaban 5mg patient information leaflet | 1.86 | 0.7 | 5991 | 91 |
| apixaban patient information leaflet | 0.18 | 0.2 | 4331 | 14 |
| apixaban patient fact sheet | 0.76 | 0.8 | 4203 | 21 |
